146 related articles for article (PubMed ID: 26879869)
1. Celecoxib enhanced the cytotoxic effect of cisplatin in chemo-resistant gastric cancer xenograft mouse models through a cyclooxygenase-2-dependent manner.
Xu HB; Shen FM; Lv QZ
Eur J Pharmacol; 2016 Apr; 776():1-8. PubMed ID: 26879869
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2.
Xu HB; Shen FM; Lv QZ
Eur J Pharmacol; 2015 Dec; 769():1-7. PubMed ID: 26407653
[TBL] [Abstract][Full Text] [Related]
3. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M
Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer.
Lin XM; Li S; Zhou C; Li RZ; Wang H; Luo W; Huang YS; Chen LK; Cai JL; Wang TX; Zhang QH; Cao H; Wu XP
Int J Biochem Cell Biol; 2019 Nov; 116():105610. PubMed ID: 31518663
[TBL] [Abstract][Full Text] [Related]
5. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin.
Hou G; Bai Y; Jia A; Ren Y; Wang Y; Lu J; Wang P; Zhang J; Lu Z
Can J Physiol Pharmacol; 2020 Jul; 98(7):449-458. PubMed ID: 32058824
[TBL] [Abstract][Full Text] [Related]
7. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2015 Mar; 36(3):1445-53. PubMed ID: 25547433
[TBL] [Abstract][Full Text] [Related]
8. Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.
Guo XF; Liu JP; Ma SQ; Zhang P; Sun WD
Biomed Pharmacother; 2018 Jul; 103():67-74. PubMed ID: 29635130
[TBL] [Abstract][Full Text] [Related]
9. Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line.
Wang CH; Zheng WB; Qiang O; Tang CW
J Dig Dis; 2009 May; 10(2):91-8. PubMed ID: 19426390
[TBL] [Abstract][Full Text] [Related]
10. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
11. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
12. Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo.
Xu HB; Shen ZL; Fu J; Xu LZ
Phytomedicine; 2014 Sep; 21(11):1221-9. PubMed ID: 25172783
[TBL] [Abstract][Full Text] [Related]
13. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway.
Li P; Hu J; Shi B; Tie J
Biochem Biophys Res Commun; 2020 Oct; 531(3):320-327. PubMed ID: 32800561
[TBL] [Abstract][Full Text] [Related]
14. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203.
You HY; Xie XM; Zhang WJ; Zhu HL; Jiang FZ
In Vitro Cell Dev Biol Anim; 2016 Sep; 52(8):857-63. PubMed ID: 27142767
[TBL] [Abstract][Full Text] [Related]
15.
Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression.
Huang YS; Xue Z; Zhang H
Med Oncol; 2015 Feb; 32(2):470. PubMed ID: 25579168
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633
[TBL] [Abstract][Full Text] [Related]
18. miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway.
Zhou C; Chen L; Chen R; Xu F; Huang Z; Huang R; Wang W; Xu Q
J Chemother; 2022 Feb; 34(1):35-44. PubMed ID: 34167436
[TBL] [Abstract][Full Text] [Related]
19. ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines.
Li W; Jie Z; Li Z; Liu Y; Gan Q; Mao Y; Wang X
Mol Med Rep; 2014 Jun; 9(6):2423-8. PubMed ID: 24699918
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]